2023-01-24 13:00:00

Green Mountain Biotech and MeNow Announce Collaboration for AI-Based Development of Skincare Products Based on...

Logo PR Newswire
PR Newswire

By combining their expertise in artificial intelligence and Chinese medicinal plants, Green Mountain Biotech and MeNow are identifying new plant combinations for treating a variety of skin conditions

TEL AVIV, Israel, Jan. 24, 2023 /PRNewswire/ -- Green Mountain Biotech (GMB), a raw material company developing and supplying innovative multifunctional botanical ingredients to the skincare industry, and MeNow, an AI company focusing on understanding effects of candidate molecules in a computational model of the skin, announced today the successful initiation of an ambitious and innovative project, aiming to identify new plant combinations targeted at skin conditions.

During this project, medicinal plants from the Chinese pharmacopeia selected by GMB scientists were automatically scanned using MeNow's innovative patent-pending algorithms to predict their effects on different skin conditions. An additional innovative developed by MeNow was used to forecast the market potential of the medicinal plants. One of the most interesting outcomes was the ability to predict the combinations of individual herbs that may show enhanced therapeutic potency.

"The results shed new light into mechanisms of action leading to development of potent herbal treatments, offering new solutions for people suffering from life-impacting skin issues," said Dr. Yonit Bomstein, Co-Founder and Head of R&D at GMB. "We are confident that we will be able to leverage the data generated in this amazing project to develop and introduce new lines of innovative and potent dermocosmetic products to the market."

"This project marks the beginning of a new era in the world of cosmetics," said Dr Hilla Ben-Hamo, Co-founder and CEO at MeNow. "No-one before has combined the latest innovation of deep-learning technologies with traditional medicinal plants to discover brand-new formulations and it is thrilling to be at the forefront."

About Green Mountain Biotech: GMB develops, manufactures and markets best-in-class, premium quality dermocosmetic ingredients extracted from Chinese medicinal plants for the cosmetic and personal care industries. Backed by leading scientists and researchers, the botanical materials undergo rigorous testing for efficacy and safety, from field to final botanical extracts and blends.

About MeNow: MeNow leverages the latest development in artificial intelligence, deep technologies and chemo-informatics to predict the effect of cosmetic ingredients on a virtual model of the user's skin. By understanding the molecular structure of the products and integrating millions of data points, MeNow aims to improve skin health worldwide by helping design better cosmetic formulations and providing a platform for personalized recommendations that ensures that each and every product respects the user's skin biology.

Green Mountain Biotech contact person: Dr. Yonit Bomstein yonit@greenmbio.com

MeNow contact person: Dr. Hilla Arbel hillaarbel@gmail.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/green-mountain-biotech-and-menow-announce-collaboration-for-ai-based-development-of-skincare-products-based-on-traditional-chinese-medicine-301729057.html

SOURCE Green Mountain Biotech; MeNow

Logo PR Newswire
Regen BioPharma, Inc. invites individual and institutional investors as well as advisors and analysts to attend its real-time, interactive presentation at...

Logo PR Newswire
New York City-Based Skin Care Boutique Tackles Skin Issues Affecting All Skin Tones NEW YORK, Jan. 24, 2023 /PRNewswire/ -- Winter is one of the hardest...

Logo The Wall Street Journal
TechnologyBy Berber Jin2023-01-23 15:23:00
Software giant to expand use of artificial intelligence in its products

Logo South China Morning Post
Business / FinanceBy Iris Ouyang2023-01-24 07:00:16
Company aims to apply AI and automation to discovery of new industrial materials, a key strategic priority for China The Tencent and Softbank-backed firm...

Logo GlobeNewswire
SciencePress Release2023-01-24 12:00:00
TORONTO, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG. |. OTCQB: PSYGF ) (Psyence or the Company ), a life science biotechnology company...

Logo GlobeNewswire
SciencePress Release2023-01-24 09:00:00
AVT02 as Simlandi is the first biosimilar approved under the strategic partnership between Alvotech and Bioventure REYKJAVIK, Iceland and DUBAI, United Arab...

Logo PR Newswire
VANCOUVER, BC, Jan. 23, 2023 /CNW/ - Modern Plant Based Foods Inc., (CSE: MEAT) ("Modern Plant Based Foods") or (the "Company"), an award-winning plant-based...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-23 14:25:00
Akston Biosciences Corporation, a clinical-stage biotechnology company, today announced that John T. Preston, a founder of TEM Capital, has joined its Board...

TechnologyBy Ashley Capoot2023-01-23 14:44:06
Key Points Microsoft announced on Monday a new multiyear, multibillion-dollar investment with the artificial intelligence lab OpenAI. The investment marks...

Logo GlobeNewswire
SciencePress Release2023-01-24 08:00:00
Helsinn and Immedica enter exclusive partnership for commercialisation of cancer supportive care products in core European markets LUGANO, Switzerland and...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-24 07:00:00
Axion BioSystems, a leader in live-cell analysis tools, today announced the full integration of imaging innovator CytoSMART Technologies into the Axion...

Logo Nasdaq
Business / FinanceBy Rtt News2023-01-24 10:06:59
(RTTNews) - Alvotech (ALVO) and Bioventure Tuesday announced manufacturing and distribution approval of AVT02, a biosimilar of Humira, by the Saudi Food and...

Logo PR Newswire
HealthPress Release2023-01-24 10:56:00
Two successful exits – Syndesi and BioPhero Four portfolio companies reported clinical data from first in class targets (Galecto, NMD Pharma, Heparegenix and...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-01-24 14:06:00
1906 Edibles, Powered by Unlokt, Expected to be the Industry's Cleanest, Safest, Fastest, and Most Predictable DENVER, Jan. 24, 2023 /PRNewswire/ -- 1906, an...

Logo The New York Times
Business / FinanceBy Cade Metz2023-01-23 14:48:57
The tech giant aims to to remain at the forefront of generative artificial intelligence with its partnership with OpenAI. Microsoft has extended its...

Logo BBC
TechnologyBy Https://Www Facebook Com/Bbcnews2023-01-23 17:44:41
Microsoft has announced a multi-year, multibillion dollar investment in artificial intelligence (AI) as it extends its partnership with OpenAI. OpenAI is the...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-24 10:00:00
Gandeeva Therapeutics, Inc., a biotechnology company focused on designing and developing precision therapeutics guided by cryogenic electron microscopy...

Logo NewsFileCorp
Press Release2023-01-23 14:37:00
Calgary, Alberta--(Newsfile Corp. - January 23, 2023) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to...

Logo PR Newswire
HealthPress Release2023-01-24 14:00:00
BOSTON, Jan. 24, 2023 /PRNewswire/ -- Syner-G BioPharma Group ("Syner-G" or the "Company"), a leading provider of integrated pharmaceutical science and...

Logo PR Newswire
SAN JOSE, Calif., Jan. 24, 2023 /PRNewswire/ -- Complete Genomics Inc., a global life science tools leader and subsidiary of MGI Tech Co., Ltd. ("MGI"),...